Skip to main content
Publish date:

Barr Pharma Pravachol Clearance

It wants to lower people's cholesterol.

Generic drug maker

Barr Pharmaceuticals

(BRL)

, said Tuesday that its subsidiary

Pliva

has received final approval from the Food and Drug Administration for its Pravastatin tablets.

TheStreet Recommends

The Woodcliff Lake, N.J.-based Barr said that the tablets are a generic version of

Bristol-Myers Squibb's

(BMY) - Get Bristol-Myers Squibb Company Report

Pravachol tablets used for treatment of coronary conditions. The company plans to launch the product immediately.

Pliva added that it has also received tentative approval for its Pravastatin 80mg tablets and plans to launch the product following the expiration of a competitors 180-day generic drug exclusivity period and subsequent final approval of Pliva's application.

This story was created through a joint venture between TheStreet.com and IRIS.